UK markets open in 4 hours 54 minutes
NIKKEI 225
38,053.58 -175.53 (-0.46%) HANG SENG
18,842.44 -121.24 (-0.64%) CRUDE OIL
77.80 -0.46 (-0.59%) GOLD FUTURES
2,364.60 -10.40 (-0.44%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
49,019.00 +419.76 (+0.86%)
GILD Jan 2026 42.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:15PM EDT. Market open.
| Previous close | 1.5000 |
| Open | 1.2800 |
| Bid | 1.2000 |
| Ask | 1.3900 |
| Strike | 42.50 |
| Expiry date | 2026-01-16 |
| Day's range | 1.2800 - 1.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 14 |
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif., May 09, 2024--Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma program. Anito-cel is the first BCMA CAR T to be investigated in multiple myeloma that utilizes Arcellx’s novel and compact D-Domain binder.
GuruFocus.comDecoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
© 2024 Yahoo. All rights reserved.